Cargando…
Clinical-scale expansion of mesenchymal stromal cells: a large banking experience
BACKGROUND: Mesenchymal stromal cells (MSC) are largely investigated in clinical trials aiming to control inappropriate immune reactions (GVHD, Crohn’s disease, solid organ transplantation). As the percentage of MSC precursors in bone marrow is very low, these must be expanded in vitro to obtain the...
Autores principales: | Lechanteur, Chantal, Briquet, Alexandra, Giet, Olivier, Delloye, Olivier, Baudoux, Etienne, Beguin, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875672/ https://www.ncbi.nlm.nih.gov/pubmed/27207011 http://dx.doi.org/10.1186/s12967-016-0892-y |
Ejemplares similares
-
MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process
por: Lechanteur, Chantal, et al.
Publicado: (2021) -
Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial
por: Grégoire, Céline, et al.
Publicado: (2022) -
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
por: Rowart, Pascal, et al.
Publicado: (2015) -
Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
por: Servais, Sophie, et al.
Publicado: (2023) -
Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model
por: Grégoire, Céline, et al.
Publicado: (2019)